Objective: To report the effect of sublingual atropine sulfate to treat drooling in children with cerebral palsy by comparing the results of the Drooling Impact Scale in a non-controlled open clinical trial.
Results: Twenty-five children were assessed. The difference in the mean scores of the pre- and post-treatment scales reached statistical significance.